Altered Cortical GABA Neurotransmission in Schizophrenia: Insights into Novel Therapeutic Strategies

E-ISSN： 1873-4316|13|8|1557-1562

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.13, Iss.8, 2012-06, pp. : 1557-1562

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction

By Lewis David Volk David Hashimoto Takanori

Psychopharmacology, Vol. 174, Iss. 1, 2004-06 ,pp. : 143-150

Springer Publishing Company

Access to resources Recommend Favorite

Is Dopamine Neurotransmission Altered in Prodromal Schizophrenia? A Review of the Evidence

Current Pharmaceutical Design, Vol. 18, Iss. 12, 2012-04 ,pp. : 1568-1579

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Therapeutic Strategies for Dementia

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 15, Iss. 2, 2016-03 ,pp. : 141-241

Bentham Science Publishers

Access to resources Recommend Favorite

Insights into the structure and function of 5-HT2 family serotonin receptors reveal novel strategies for therapeutic target development

By Shapiro David A Roth Bryan L

Expert Opinion on Therapeutic Targets, Vol. 5, Iss. 6, 2001-12 ,pp. : 685-695

Informa Healthcare

Access to resources Recommend Favorite

Editorial (Hot Topic: Androgen Receptor and Prostate Cancer: New Insights in an Old Target Translate into Novel Therapeutic Strategies)

Current Drug Targets, Vol. 14, Iss. 4, 2013-01 ,pp. : 399-400

Bentham Science Publishers

Access to resources Recommend Favorite